About: Saratoga Opthalmology

Posts by Saratoga Opthalmology:

Week in review: Corneal shield, Novartis acquisition, preloaded IOL

This week, research hints that the cornea may have resistance against SARS-CoV-2, Novartis invests in a novel optogenetic gene therapy technology, and Bausch + Lomb launches a preloaded toric IOL. Source: AAO

Posted on: Nov 6 2020
By: Saratoga Opthalmology
Leave a reponse

Changes to indoor environment may improve dry eye signs and symptoms

This prospective cross-sectional study examines the impact of indoor environments on symptoms and signs of dry eye. Source: AAO

Posted on: Nov 5 2020
By: Saratoga Opthalmology
Leave a reponse

Does time equal vision in AQP4-IgG positive NMOSD optic neuritis?

This study evaluates the impact of rapid high-dose intravenous methylprednisolone pulse therapy in patients with serum anti-aquaporin-4 immunoglobulin G (AQP4-IgG)–positive neuromyelitis optica spectrum disorders (NMOSDs) who had an attack of optic neuritis. Source: AAO

Posted on: Nov 4 2020
By: Saratoga Opthalmology
Leave a reponse

Patient’s age tied to reoperation risk after retinal detachment repair

This IRIS Registry study evaluated reoperation rates of patients who underwent a primary noncomplex retinal detachment repair between 2013 and 2016. Source: AAO

Posted on: Nov 2 2020
By: Saratoga Opthalmology
Leave a reponse

Week in review: COVID again, FDA approvals, VEGF alternative

This week, clinicians report another possible ocular manifestation of COVID-19, the FDA approves new drugs for dry eye and pediatric vernal keratoconjuncitivitis, and researchers propose a new mechanism to treat retinal diseases. Source: AAO

Posted on: Oct 30 2020
By: Saratoga Opthalmology
Leave a reponse

First-line SLT treatment may help delay visual field progression

This study assessed visual field outcomes in patients undergoing selective laser trabeculoplasty (SLT) versus medical therapy as a first-line treatment for ocular hypertension and glaucoma. Source: AAO

Posted on: Oct 29 2020
By: Saratoga Opthalmology
Leave a reponse

Aggressive posterior ROP appears to be more common among infants with comorbidities

This retrospective analysis aimed to quantitatively characterize aggressive posterior retinopathy of prematurity in a large cohort. Source: AAO

Posted on: Oct 28 2020
By: Saratoga Opthalmology
Leave a reponse

Is there a correlation between uveitic glaucoma and fluocinolone implants?

Researchers assessed the long-term outcomes of uveitic glaucoma in eyes undergoing systemic therapy or fluocinolone acetonide implant. Source: AAO

Posted on: Oct 26 2020
By: Saratoga Opthalmology
Leave a reponse

Week in review: KDB Glide, geographic atrophy, opsin therapy

This week, the second-generation Kahook Dual Blade is set to hit U.S. markets, pegcetacoplan appears to slow geographic atrophy and a new light-sensing protein offers hope for people with degenerative retinal diseases. Source: AAO